|Jan. 13; 1-2 p.m. ET|
Innovation as Discipline: Tools for Discovering Better Patient Care
This activity will focus on the difference between quality improvement and innovation in healthcare practice, techniques for validation, and how to add emotion back into automation as these modalities are integrated into practice. It will also elucidate how to better define and approach issues surrounding the integration of automated and alternative modalities into the patient care process that can help improve the attainment of clinical goals.
Live, Accredited Webcast. This activity will not be available on-demand.
|Mar. 16; 1-2 p.m. ET|
Understanding and Preventing Burnout: Improving Health Care Outcomes
This activity will discuss contributing factors to burnout, its impact on the health and well-being of HCPs and their patients, interventions to decrease overall stress and how burnout can influence patient care and health care outcomes.
Live, Accredited Webcast.
Essentials of Oncology, Solid Organ and Blood/Marrow Transplant Management for the Health Care Team
|Sept. 27–29||30th Annual National Conference|
Missed the live webcasts?Click on the activity title to take the on-demand webcast.
|Nov. 17, 2020|
As Science Moves to Genetic Testing and Treatment: Part 2, Genetic-Informed Treatments
Genetics/genomics is a vast and ever-growing area. Health care professionals (HCPs) must understand how it can impact the treatment plan for individuals with chronic illness, serious illness and/or rare diseases. This activity will discuss the importance of data and evidence regarding the use of genetics/genomics in treatment planning.
|Sept. 22, 2020|
The Impact of Aging, Hearing Loss and Cognitive Burden on Health Literacy on Older Adults
This activity will discuss the association between hearing loss and cognitive burden, as well as the potential impact of untreated hearing loss. It will provide communication and management techniques for caregivers to accommodate changes in the cognitive status of those with hearing loss, as well as tools and strategies that are recommended by the Hearing Loss Association of America (HLAA) and how these can be put into practice.
|July 7, 2020|
Genetic Testing and Treatment: Part 1, Neuromuscular Diseases
The goal of this activity is to assist HCPs in understanding how the vast and growing field of genetic testing can impact the plan of care and treatment for individuals with neuromuscular diseases. The importance of gathering an individual’s comprehensive history and exam, along with use of current available evidence to inform decisions on next steps in evaluation and testing, will be reviewed. Additionally, faculty will discuss the important role of a genetic counselor during the decision-making process.
|June 16, 2020|
Tips and Techniques for Accommodating Hearing Loss
For people living with hearing loss, conversations can be a challenge, so effective techniques to communicate better with those who are hearing impaired can positively impact individuals with hearing loss and their significant others and/or caregivers. This activity will discuss challenges surrounding hearing health care for older adults and highlight effective techniques, tools and resources for the hearing impaired for long-term health and quality of life.
|June 9, 2020|
Direct-to-Consumer Genetic Testing: Providing Personalized Medicine
Genetic testing, marketed directly to customers, has become more and more prevalent and is expanding the number of people who are obtaining information about their DNA (or genome). Consumers send in a DNA sample and receive their results directly; in most cases, bypassing a health care professional (HCP). Consumers may receive confusing or unexpected results and may be in need of competent guidance from a knowledgeable HCP. This activity will provide an overview on direct-to-consumer (DTC) genetic testing, the role of HCPs in helping consumers make educated decisions about using these services and the future of DTC genetic testing.
|April 28, 2020||Pharmacogenomics: Providing Personalized Medicine|
Pharmacogenomics is an important part of precision medicine; it is the study of how genetic makeup can affect a person's response to a drug. Health care professionals (HCPs) can use pharmacogenomic information to help decide the most appropriate treatment for each individual. This activity will provide an overview on the clinical indications for using pharmacogenomics and explore resources for interpreting pharmacogenomics. The basic science of liver enzymes and their genetic variation will also be discussed.